Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice

Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice

Michael R Preusch,1,2 Nicholas Ieronimakis,1 Errol S Wijelath,3 Sara Cabbage,1 Jerry Ricks,1 Florian Bea,2 Morayma Reyes,1 Joanne van Ryn,4 Michael E Rosenfeld1,5 1Department of Pathology, University of Washington, Seattle, WA, USA; 2Department of Internal Medicine, University of Heidelberg, Heidel...

Full description

Bibliographic Details
Main Authors: Preusch MR, Ieronimakis N, Wijelath ES, Cabbage S, Ricks J, Bea F, Reyes M, van Ryn J, Rosenfeld ME
Format: Article
Language:English
Published: Dove Medical Press 2015-09-01
Series:Drug Design, Development and Therapy
Online Access:https://www.dovepress.com/dabigatran-etexilate-retards-the-initiation-and-progression-of-atheros-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/dabigatran-etexilate-retards-the-initiation-and-progression-of-atheros-peer-reviewed-article-DDDT

Similar Items